PCCA's Clinical Services team is populated with hard-working, dedicated pharmacy professionals who strive each day to make a difference in pharmacy compounding. As a team, they act as a cornerstone of PCCA's abiding desire to provide pharmacies with answers to tough questions. The Clinical Services Spotlight is a limited series of articles designed to highlight a singular member of the Clinical Services team. This article focuses on Bruce Biundo, a man who embodies the very heart of PCCA service.

Establishing yourself as a men's health consultant can be a differentiating factor between yourself and your competitors. Between HRT, prostate health and supplementation, Bruce Biundo of PCCA Clinical Services is happy to provide methods you can use to establish yourself as the authoritative voice on men's health to those in your area.

Thank you to all of our readers and subscribers for supporting the PCCA blog, your support is what makes it the best compounding pharmacy blog online! We’re grateful to be able to produce content that professionals in the pharmacy compounding industry find valuable. With that said, come check out the top five, most valuable PCCA Blog Posts of 2019 that you might have missed!

In the first part of this article, Pamela, Nat, and Sara shined a light on new health risk information compounders should consider when providing bioidentical hormone replacement therapy. In this second part of the article, they dive deeper into the BHRT conversation, discussing compounded topical estrogen as an option.

Compounded bioidentical hormone replacement therapy (BHRT) is an important treatment option for women around the world. Colleagues and patients alike come to PCCA experts Pamela Smith, Nat Jones and Sara Hover for guidance. In this article, our three experts cover this all-too-important topic in the HRT conversation, on what current literature says about the usage of oral vs. topical estrogen discussion.

Yi Liu, PharmD, PhD, PCCA Research Pharmacist has an exciting PCCA Science update on case studies, new product testing and comprehensive formula analysis revolving around our PCCA bases. Check it out!

PCCA launches an exciting new base at their 2019 International Seminar. Click here to learn all about it.

Compounders who use progesterone in their formulations are faced with the question, "Should I used micronized or wettable progesterone?" With the help of PCCA's Clinical Services team, we're here to help guide you through making the best decision in specific situations.

Compounding pharmacies have been using PCCA's VersaBase Cream for years. Today, we'd like to talk to you about VersaBase's incredible ability to assist in women's Hormone Replacement Therapy.

PCCA's own Ranel Larsen of Clinical Services gives the low-down on our HRT Symposium. She has lots to say about how compounders use HRT to help patients around the globe. "It is the compounding industry’s biggest hormone replacement event," she says, "And this year was no exception.."